Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
STRIVE
NCT03335839Phase 3Completed
- Sponsor
- Population Health Research Institute
- Start
- Apr 2018
- Primary completion
- Sep 2024
- Modality
- rProtein (Recombinant Protein), Biologic
- Countries
- 1
01
Overview
A Phase 3 trial of tissue-plasminogen activator in ST-segment elevation myocardial infarction (STEMI), sponsored by Population Health Research Institute. Started Apr 2018; status: completed.
02
Drugs
tissue-plasminogen activator
03
Conditions
ST-segment elevation myocardial infarction (STEMI)
Beyond the preview
Go deeper on NCT03335839.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03335839.